Clinical Trials List
2022-09-01 - 2026-12-31
Phase III
Recruiting7
ICD-10E04.0
Nontoxic diffuse goiter
ICD-9240.0
Goiter, specified as simple
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 蔡淳光 Division of Hematology & Oncology
- Po-Shen Ko Division of Hematology & Oncology
- 陳玫均 Division of Hematology & Oncology
- 陳玟均 Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Sheng-Hsuan Chien Division of Hematology & Oncology
- Hao-Yuan Wang Division of Hematology & Oncology
- Ting-An Lin Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Yao-Chung Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林政賢 未分科
- 陳虹潔 Division of General Internal Medicine
- YU-HSUAN SHIH Division of General Internal Medicine
- 陳文賢 Division of General Internal Medicine
- 滕傑林 未分科
- ZHENG-WEI ZHOU Division of General Internal Medicine
- HSIN-CHEN LIN Division of General Internal Medicine
- 滕傑林 Division of General Internal Medicine
- Tsung -Chih Chen Division of General Internal Medicine
- 林欣辰 未分科
- CHENG-HSIEN LIN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ting Hsu 未分科
- 顏志傑 未分科
- Ya-Ping Chen 未分科
- Chun-Hui Lee 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
525 participants
